DK1492821T3 - Jerndextrinforbindelser til behandling af jernmangelanæmi - Google Patents

Jerndextrinforbindelser til behandling af jernmangelanæmi

Info

Publication number
DK1492821T3
DK1492821T3 DK03746252T DK03746252T DK1492821T3 DK 1492821 T3 DK1492821 T3 DK 1492821T3 DK 03746252 T DK03746252 T DK 03746252T DK 03746252 T DK03746252 T DK 03746252T DK 1492821 T3 DK1492821 T3 DK 1492821T3
Authority
DK
Denmark
Prior art keywords
iron
treatment
deficiency anemia
dextrin compounds
iron deficiency
Prior art date
Application number
DK03746252T
Other languages
English (en)
Inventor
Lars Christensen
Hans Berg Andreasen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Application granted granted Critical
Publication of DK1492821T3 publication Critical patent/DK1492821T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK03746252T 2002-04-09 2003-04-08 Jerndextrinforbindelser til behandling af jernmangelanæmi DK1492821T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200512 2002-04-09

Publications (1)

Publication Number Publication Date
DK1492821T3 true DK1492821T3 (da) 2006-11-27

Family

ID=28459423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03746252T DK1492821T3 (da) 2002-04-09 2003-04-08 Jerndextrinforbindelser til behandling af jernmangelanæmi

Country Status (23)

Country Link
US (1) US20030191090A1 (da)
EP (1) EP1492821B1 (da)
JP (1) JP4520748B2 (da)
KR (1) KR20040104560A (da)
CN (1) CN1309741C (da)
AR (1) AR039396A1 (da)
AT (1) ATE335008T1 (da)
AU (1) AU2003226923B2 (da)
BR (1) BR0308773A (da)
CA (1) CA2480365A1 (da)
DE (1) DE60307249T2 (da)
DK (1) DK1492821T3 (da)
EA (1) EA006720B1 (da)
ES (1) ES2270070T3 (da)
MX (1) MXPA04009770A (da)
NO (1) NO20044131L (da)
NZ (1) NZ535761A (da)
PL (1) PL373403A1 (da)
PT (1) PT1492821E (da)
SI (1) SI1492821T1 (da)
UA (1) UA79452C2 (da)
WO (1) WO2003087164A1 (da)
ZA (1) ZA200407658B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
WO2005087216A2 (de) * 2004-03-12 2005-09-22 Eberhard-Karls-Universität Tübingen Behandlung von anämischen zuständen durch inhibierung der erythrozytenapoptose
JP4550543B2 (ja) * 2004-10-07 2010-09-22 松谷化学工業株式会社 鉄、マグネシウム又は亜鉛成分に対する食品用マスキング剤
DK1848446T3 (da) 2005-02-09 2010-02-15 Vifor Int Ag anvendelse af jern(III)-kompleksforbindelser
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
DK1973549T3 (da) 2006-01-06 2016-11-21 Vifor (International) Ag Fremgangsmåder og sammensætninger til indgivelse af jern
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
HRP20170230T1 (hr) 2009-03-25 2017-04-07 Pharmacosmos Holding A/S Stabilan spoj željezo oligosaharida
CN106176808A (zh) 2010-10-19 2016-12-07 长春纳米生技公司 金属离子纳米簇组合物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
JP6189309B2 (ja) * 2011-10-13 2017-08-30 ヴィダシム・インコーポレーテッド 鉄−繊維組成物、その調製および使用
EP2983527B1 (en) 2013-03-08 2019-04-24 Vidasym, Inc. Metal ion-functional fiber component complex compositions, preparation and uses thereof
EP2997968A1 (en) 2014-09-22 2016-03-23 Ioulia Tseti Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
WO2018198135A1 (en) * 2017-04-26 2018-11-01 Mylan Laboratories Ltd. Improved process for the preparation of iron complex
CN107519198A (zh) * 2017-07-21 2017-12-29 南通市第人民医院 一种右旋糖酐铁注射液及其制备方法
EP3932535A1 (en) 2020-07-01 2022-01-05 Vifor Fresenius Medical Care Renal Pharma, Ltd. Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid
AU2022323733A1 (en) * 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) * 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
ES360433A1 (es) * 1968-11-20 1970-11-16 Rocador Sa Procedimiento para la fabricacion de un compuesto de hierrotrivalente apropiado para administracion por via oral.
US3686397A (en) * 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
JPS6128502A (ja) * 1985-04-06 1986-02-08 Nippon Zoki Pharmaceut Co Ltd デキストリン・ヒドロキシカルボン酸・第二鉄多核複合体の製造方法
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Also Published As

Publication number Publication date
EA006720B1 (ru) 2006-04-28
ES2270070T3 (es) 2007-04-01
EP1492821B1 (en) 2006-08-02
JP2005530863A (ja) 2005-10-13
US20030191090A1 (en) 2003-10-09
UA79452C2 (en) 2007-06-25
JP4520748B2 (ja) 2010-08-11
HK1069589A1 (en) 2005-05-27
DE60307249T2 (de) 2007-03-15
ZA200407658B (en) 2006-07-26
AU2003226923B2 (en) 2006-08-17
AR039396A1 (es) 2005-02-16
CN1309741C (zh) 2007-04-11
CA2480365A1 (en) 2003-10-23
NO20044131L (no) 2004-09-29
EA200401330A1 (ru) 2005-02-24
ATE335008T1 (de) 2006-08-15
MXPA04009770A (es) 2004-12-13
WO2003087164A1 (en) 2003-10-23
NZ535761A (en) 2007-09-28
KR20040104560A (ko) 2004-12-10
PL373403A1 (en) 2005-08-22
AU2003226923A1 (en) 2003-10-27
DE60307249D1 (de) 2006-09-14
PT1492821E (pt) 2006-12-29
BR0308773A (pt) 2005-02-09
CN1646568A (zh) 2005-07-27
EP1492821A1 (en) 2005-01-05
SI1492821T1 (sl) 2006-12-31

Similar Documents

Publication Publication Date Title
DK1492821T3 (da) Jerndextrinforbindelser til behandling af jernmangelanæmi
DK1661563T3 (da) Forbindelser der påvirker ghicokinase
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1355644T3 (da) Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
DK1572670T3 (da) 5-substitueret-pyrazin eller -pyridin-glucokinaseaktivatorer
IS7362A (is) Kínasólín efnasambönd
IS6971A (is) Ný efnasambönd
ATE368042T1 (de) Cephemverbindungen
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
IS7381A (is) Efnasambönd
IS7414A (is) Oxó-azabísýklísk efnasambönd
NO20045659L (no) Forbindelser
DK1401277T3 (da) Aminoacetonitrilforbindelser til bekæmpelse af endoparasitter
DE60136750D1 (de) Werkstückträger
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
DK1451177T3 (da) Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne
FI20031087A0 (fi) Menetelmä nosturin ohjaamiseksi
ATE394370T1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen
DE50115802D1 (de) Dafür
DE60203556D1 (de) Bauteilträger
ATE360010T1 (de) Heterocyclische retioidverbindungen
SE0203348D0 (sv) Novel compounds
FIU20030259U0 (fi) Arinarauta
SE0100966D0 (sv) Novel compounds